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STEMI NSTEMI Unadlusiad P- 
(ll = (n = Values 
53,417) 132,551) 
Median Age (yrs) 69 (5680) 75 (63. 63) < 0.0001 
Female Sex (%) 40.4 45.8 < 0.0001 
Diabetes (%) 26.5 34.0 < O.OcOl 
Acute Aspirin (%) 88.0 84.9 < 0.0001 
Acute Heparin (%) 84.2 72.6 < O.oool 
Acute EBlocker (%) 77.8 72.2 < 0.0001 
Discharge Aspirin (%) 88.9 83.8 < 0.0001 
Discharge B-Blocker (%) 83.4 70.3 < 0.0001 
Discharge ACE-Inhibitor (%) 58.0 51.2 < 0.0001 
Discharge Lipid Lowering Agent 86.7 85.7 0.073 
(%) 
In-Hospital Mortality (%) 14.5 12.3 < 0.0001 
11:30 a.m. 
885-5 Opportunities to Improve Outpatient Compliance of 
Evidence-Based Therapy in Patients With Known Prior 
Coronary Artery Disease Admitted for Acute Coronary 
Syndrome 
Richard F. Otten, Eva M. Kline-Rogers, Bruce Rogers, Prasanth Lmgam, Yassar 
Almanaseer, Fauzlya Hassan. Firas Al-Marayati. Kim A. Eagle, Jianming Fang, 
University of Michigan, Ann Arbor, Ml 
Background: Aspirin (ASA), beta blockers (68). ace-inhibitors (ACE), and lipid lowering 
agents (LL) decrease morbidity/mortality in eligible patients with coronary attery disease 
(CAD). We assessed use of these medications among patients with known CAD admit- 
ted for acute coronary syndromes. 
Methods: 443 of 700 consecutive patients admitted to our health system 8/22/00 to 12/4/ 
01 had known CAD at admission and were contaded for 8 month follow up after dis- 
charge. We evaluated ASA, BB, ACE and LL among ‘ideal’ patients (no contraindica- 
tions) at admission, discharge, and 6 months post discharge. 
Results: At admission, a substantial percentage of patients with known CAD were not on 
evidence based therapies. While 80-96% of patients were given these agents at dis- 
charge, by 6 months a considerable fraction were no longer on therapy. 
Overall Adherence & Adherence at 6 mo. comparing patvats on/not on medication at 
admission 
On admission (all) 
At discharge (all) 
At 6 mo. (all) 
At 6 mo. (on med at admission)’ 
At 6 mo. (not on med at admlssionr 
ASA’ BB ACE LL 
68.9% 55.7% 57.6% 60.6% 
98.1% 91.8% 82.8% 86.8% 
84.1% 78.5% 57.8% 82.5% 
81.4% 81.3% 72.1% 81.3% 
80.1% 76.5% 64.6% 75.5% 
‘Includes ASA or other anti-platelet and/or wadarin. 
+% among patients who were discharged on the medication. 
Conclusions: Among patients with known CAD admitted for an acute coronary syn- 
drome, a substantial fraction are not on evidence based medications when admitted. 
Despite efforts to optimize treatment goals at discharge, adherence to BB, ACE, and 
ASA falls substantially by 6 months. There is a non-significant trend for non-adherence to 
be more common among patients with prior CAD not taking these agents prior to acute 
coronary syndrome admission. Further studies are needed to identify methods of 
increasing adherence to key therapies in patients after acute coronary syndrome. 
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885-6 Relationship Between Time of Day/Day of Week and 
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Mauro M. Moscucci, Dean Smith, Debabrata Mukherjee, Cecelia Montoye, Michael J. 
O’Donnell, Anthony C. DeFranco, William L. Meengs, Ann Maxwell-Eward. John G. 
McGinnity. Kirit Patel, David Share, for the Blue Cross Blue Shield of Michigan 
Cardiovascular Consollium (BMC2), University of Michigan Health System, Ann Arbor, 
Ml 
Objective: To determine if outcomes of primary PCI for acute myocardial infarction (AMI) 
are affected by the time of procedure (time of day, day of week). Methods: Clinical proce- 
dural and outcome data on 25,144 consecutive PCls were prospectively collected 
between July 1997 and September 2001 in a consortium of 8 hospitals. Of these, 3,908 
primary PCI were performed in patients with AMI (within 24 hours). Clinical outcomes of 
patients undergoing PCI during the night and weekends were compared with those of 
patients undergoing PCI during the day and weekdays. Nighttime was defined as 
between 6 PM and 8 AM. The primary endpoint was a composite major adverse cardiac 
event (MACE) including death, CABG, stroke and re-infarction. Results: The unadjusted 
MACE rata was significantly higher for patients treated during weekends or nighttime 
when compared with patients treated during weekdays or daytime (Table). After adjust- 
ment for comorbidities, patients treated during weekends had a 41% increased risk of 
MACE (adjusted OR 1.41,95% Cl 1.08-l .84, p=O.Ol), and a 45% increased risk of death 
in the hospital (adjusted OR 1.45, 95% Cl 1 .Ol-2.07, p=O.O45). A non-significant trend 
toward worse MACE was also observed in patients undergoing PCI during nighttime 
(Adjusted OR 1.20, 95% C.I. 0.95-l .53, p=O.13). Conclusions: Patients with AMI under- 
going primary PCI during weekends have a higher risk of major adverse cardiac events 
and in hospital modality. It needs to be determined whether this might ba related to pro- 
cess of care. 
Any CABG 
Stroke 
w-infarction 
Death 
MACE 
Nighttime Daytime p Weekend Weekdays p 
4.4 3.0 0.03 4.4 3.2 0.09 
1.4 1.0 0.24 0.7 1.2 0.26 
2.2 1.5 0.12 2.8 1.6 0.05 
7.3 6.1 0.17 8.4 6.0 0.02 
13.9 10.4 0.001 15.1 10.6 0.0004 
